{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:25:43Z","timestamp":1790792743950,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/nrrheum.2016.49","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T05:09:03Z","timestamp":1460696943000},"page":"296-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Adipokines in bone disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Elena","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Frommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"BFnrrheum201649_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg, H. & Moschen, A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772\u2013783 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum201649_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrrheum.2011.107","volume":"7","author":"R Gomez","year":"2011","unstructured":"Gomez, R.  et al. What's new in our understanding of the role of adipokines in rheumatic diseases? Nat. Rev. Rheumatol. 7, 528\u2013536 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201649_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/art.30291","volume":"63","author":"E Neumann","year":"2011","unstructured":"Neumann, E., Frommer, K. W., Vasile, M. & Muller-Ladner, U. Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum. 63, 1159\u20131169 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201649_CR4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.290.13.1709-c","volume":"290","author":"A Sch\u00e4ffler","year":"2003","unstructured":"Sch\u00e4ffler, A.  et al. Adipocytokines in synovial fluid. JAMA 290, 1709\u20131710 (2003).","journal-title":"JAMA"},{"key":"BFnrrheum201649_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/ard.2010.140046","volume":"70","author":"IR Klein-Wieringa","year":"2011","unstructured":"Klein-Wieringa, I. R.  et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann. Rheum. Dis. 70, 851\u2013857 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.joca.2006.11.006","volume":"15","author":"PM van der Kraan","year":"2007","unstructured":"van der Kraan, P. M. & van den Berg, W. B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 15, 237\u2013244 (2007).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum201649_CR7","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2741\/4273","volume":"19","author":"MG Giganti","year":"2014","unstructured":"Giganti, M. G.  et al. Fracture healing: from basic science to role of nutrition. Front. Biosci. (Landmark Ed.) 19, 1162\u20131175 (2014).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"BFnrrheum201649_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00393-007-0182-4","volume":"66","author":"E Neumann","year":"2007","unstructured":"Neumann, E. & Schett, G. Bone metabolism: molecular mechanisms. Z. Rheumatol. 66, 286\u2013289 (in German) (2007).","journal-title":"Z. Rheumatol."},{"key":"BFnrrheum201649_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11914-013-0183-y","volume":"12","author":"R Baum","year":"2014","unstructured":"Baum, R. & Gravallese, E. M. Impact of inflammation on the osteoblast in rheumatic diseases. Curr. Osteoporos. Rep. 12, 9\u201316 (2014).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrrheum201649_CR10","doi-asserted-by":"publisher","first-page":"263625","DOI":"10.1155\/2014\/263625","volume":"2014","author":"SM Jung","year":"2014","unstructured":"Jung, S. M., Kim, K. W., Yang, C. W., Park, S. H. & Ju, J. H. Cytokine-mediated bone destruction in rheumatoid arthritis. J. Immunol. Res. 2014, 263625 (2014).","journal-title":"J. Immunol. Res."},{"key":"BFnrrheum201649_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.drudis.2014.06.025","volume":"19","author":"C Swales","year":"2014","unstructured":"Swales, C. & Sabokbar, A. Cellular and molecular mechanisms of bone damage and repair in inflammatory arthritis. Drug Discov. Today 19, 1178\u20131185 (2014).","journal-title":"Drug Discov. Today"},{"key":"BFnrrheum201649_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/annrheumdis-2012-202685","volume":"73","author":"CA Karvonen-Gutierrez","year":"2014","unstructured":"Karvonen-Gutierrez, C. A., Harlow, S. D., Jacobson, J., Mancuso, P. & Jiang, Y. The relationship between longitudinal serum leptin measures and measures of magnetic resonance imaging-assessed knee joint damage in a population of mid-life women. Ann. Rheum. Dis. 73, 883\u2013889 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR13","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.2174\/0929867311320270006","volume":"20","author":"M Scotece","year":"2013","unstructured":"Scotece, M.  et al. Leptin in joint and bone diseases: new insights. Curr. Med. Chem. 20, 3416\u20133425 (2013).","journal-title":"Curr. Med. Chem."},{"key":"BFnrrheum201649_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3899\/jrheum.130709","volume":"41","author":"AV Perruccio","year":"2014","unstructured":"Perruccio, A. V., Mahomed, N. N., Chandran, V. & Gandhi, R. Plasma adipokine levels and their association with overall burden of painful joints among individuals with hip and knee osteoarthritis. J. Rheumatol. 41, 334\u2013337 (2014).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201649_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00296-012-2401-9","volume":"33","author":"D Durmus","year":"2013","unstructured":"Durmus, D., Alayli, G., Aliyazicioglu, Y., Buyukakincak, O. & Canturk, F. Effects of glucosamine sulfate and exercise therapy on serum leptin levels in patients with knee osteoarthritis: preliminary results of randomized controlled clinical trial. Rheumatol. Int. 33, 593\u2013599 (2013).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum201649_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/rheumatology\/kes422","volume":"52","author":"C Staikos","year":"2013","unstructured":"Staikos, C.  et al. The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis. Rheumatology (Oxford) 52, 1077\u20131083 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201649_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11845-014-1072-9","volume":"183","author":"G Tian","year":"2014","unstructured":"Tian, G.  et al. Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis. Ir. J. Med. Sci. 183, 659\u2013666 (2014).","journal-title":"Ir. J. Med. Sci."},{"key":"BFnrrheum201649_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/rheumatology\/keq266","volume":"50","author":"A Stavropoulos-Kalinoglou","year":"2011","unstructured":"Stavropoulos-Kalinoglou, A.  et al. Obesity in rheumatoid arthritis. Rheumatology (Oxford) 50, 450\u2013462 (2011).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201649_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1136\/ard.2010.145672","volume":"70","author":"R Gomez","year":"2011","unstructured":"Gomez, R.  et al. Adiponectin and leptin increase IL-8 production in human chondrocytes. Ann. Rheum. Dis. 70, 2052\u20132054 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR20","doi-asserted-by":"publisher","first-page":"e52533","DOI":"10.1371\/journal.pone.0052533","volume":"7","author":"J Conde","year":"2012","unstructured":"Conde, J.  et al. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS ONE 7, e52533 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201649_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/cbin.10336","volume":"39","author":"KO Yaykasli","year":"2014","unstructured":"Yaykasli, K. O.  et al. Leptin induces ADAMTS-4, ADAMTS-5, and ADAMTS-9 genes expression by mitogen-activated protein kinases and NF-\u03baB signaling pathways in human chondrocytes. Cell Biol. Int. 39, 104\u2013112 (2014).","journal-title":"Cell Biol. Int."},{"key":"BFnrrheum201649_CR22","first-page":"589","volume":"31","author":"S Muraoka","year":"2013","unstructured":"Muraoka, S., Kusunoki, N., Takahashi, H., Tsuchiya, K. & Kawai, S. Leptin stimulates interleukin-6 production via Janus kinase 2\/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts. Clin. Exp. Rheumatol. 31, 589\u2013595 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201649_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s13075-014-0459-3","volume":"16","author":"B Bouvard","year":"2014","unstructured":"Bouvard, B.  et al. Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Res. Ther. 16, 459 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201649_CR24","doi-asserted-by":"publisher","first-page":"15778","DOI":"10.3390\/ijms150915778","volume":"15","author":"WH Yang","year":"2014","unstructured":"Yang, W. H.  et al. Leptin induces oncostatin M production in osteoblasts by downregulating miR-93 through the Akt signaling pathway. Int. J. Mol. Sci. 15, 15778\u201315790 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrrheum201649_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/en.2013-1298","volume":"155","author":"GY Liu","year":"2014","unstructured":"Liu, G. Y.  et al. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression. Endocrinology 155, 558\u2013567 (2014).","journal-title":"Endocrinology"},{"key":"BFnrrheum201649_CR26","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.33549\/physiolres.931499","volume":"57","author":"V Cirmanova","year":"2008","unstructured":"Cirmanova, V., Bayer, M., Starka, L. & Zajickova, K. The effect of leptin on bone: an evolving concept of action. Physiol. Res. 57, S143\u2013S151 (2008).","journal-title":"Physiol. Res."},{"key":"BFnrrheum201649_CR27","doi-asserted-by":"publisher","first-page":"e60706","DOI":"10.1371\/journal.pone.0060706","volume":"8","author":"M Iwata","year":"2013","unstructured":"Iwata, M.  et al. Initial responses of articular tissues in a murine high-fat diet-induced osteoarthritis model: pivotal role of the IPFP as a cytokine fountain. PLoS ONE 8, e60706 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201649_CR28","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/ar4467","volume":"16","author":"MC Laiguillon","year":"2014","unstructured":"Laiguillon, M. C.  et al. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res. Ther. 16, R38 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201649_CR29","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1002\/jbmr.480","volume":"26","author":"Y Li","year":"2013","unstructured":"Li, Y.  et al. Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. J. Bone Miner. Res. 26, 2656\u20132664 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201649_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mrfmmm.2009.06.012","volume":"690","author":"AR Moschen","year":"2010","unstructured":"Moschen, A. R., Geiger, S., Gerner, R. & Tilg, H. Pre-B cell colony enhancing factor\/NAMPT\/visfatin and its role in inflammation-related bone disease. Mutat. Res. 690, 95\u2013101 (2010).","journal-title":"Mutat. Res."},{"key":"BFnrrheum201649_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.exphem.2013.02.008","volume":"41","author":"SU Venkateshaiah","year":"2013","unstructured":"Venkateshaiah, S. U.  et al. NAMPT\/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Exp. Hematol. 41, 547\u2013557.e2 (2013).","journal-title":"Exp. Hematol."},{"key":"BFnrrheum201649_CR32","first-page":"631251","volume":"2013","author":"L Jiang","year":"2013","unstructured":"Jiang, L., Bao, J., Zhou, X., Xiong, Y. & Wu, L. Increased serum levels and chondrocyte expression of nesfatin-1 in patients with osteoarthritis and its relation with BMI, hsCRP, and IL-18. Mediators Inflamm. 2013, 631251 (2013).","journal-title":"Mediators Inflamm."},{"key":"BFnrrheum201649_CR33","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.joca.2007.12.008","volume":"16","author":"R Lago","year":"2008","unstructured":"Lago, R.  et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 16, 1101\u20131109 (2008).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFnrrheum201649_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2121-8-51","volume":"8","author":"I Kanazawa","year":"2007","unstructured":"Kanazawa, I.  et al. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol. 8, 51 (2007).","journal-title":"BMC Cell Biol."},{"key":"BFnrrheum201649_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jcb.20890","volume":"99","author":"Y Shinoda","year":"2006","unstructured":"Shinoda, Y.  et al. Regulation of bone formation by adiponectin through autocrine\/paracrine and endocrine pathways. J. Cell. Biochem. 99, 196\u2013208 (2006).","journal-title":"J. Cell. Biochem."},{"key":"BFnrrheum201649_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bone.2014.03.051","volume":"64","author":"YY Lin","year":"2014","unstructured":"Lin, Y. Y.  et al. Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3\u03b2\/\u03b2-catenin signaling in mice. Bone 64, 147\u2013154 (2014).","journal-title":"Bone"},{"key":"BFnrrheum201649_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bbrc.2015.03.168","volume":"461","author":"T Chen","year":"2015","unstructured":"Chen, T., Wu, Y. W., Lu, H., Guo, Y. & Tang, Z. H. Adiponectin enhances osteogenic differentiation in human adipose-derived stem cells by activating the APPL1\u2013AMPK signaling pathway. Biochem. Biophys. Res. Commun. 461, 237\u2013242 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201649_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/10799893.2014.898658","volume":"34","author":"EL Pacheco-Pantoja","year":"2014","unstructured":"Pacheco-Pantoja, E. L., Fraser, W. D., Wilson, P. J. & Gallagher, J. A. Differential effects of adiponectin in osteoblast-like cells. J. Recept. Signal Transduct. Res. 34, 351\u2013360 (2014).","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"BFnrrheum201649_CR39","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1038\/emm.2013.141","volume":"46","author":"YA Lee","year":"2014","unstructured":"Lee, Y. A.  et al. The role of adiponectin in the production of IL-6, IL-8, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints. Exp. Mol. Med. 46, e72 (2014).","journal-title":"Exp. Mol. Med."},{"key":"BFnrrheum201649_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","volume":"331","author":"K Oshima","year":"2005","unstructured":"Oshima, K.  et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 331, 520\u2013526 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201649_CR41","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1210\/en.2008-1639","volume":"150","author":"GA Williams","year":"2009","unstructured":"Williams, G. A.  et al. In vitro and in vivo effects of adiponectin on bone. Endocrinology 150, 3603\u20133610 (2009).","journal-title":"Endocrinology"},{"key":"BFnrrheum201649_CR42","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.febslet.2007.12.037","volume":"582","author":"N Yamaguchi","year":"2008","unstructured":"Yamaguchi, N.  et al. Adiponectin inhibits induction of TNF-\u03b1\/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett. 582, 451\u2013456 (2008).","journal-title":"FEBS Lett."},{"key":"BFnrrheum201649_CR43","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar4404","volume":"15","author":"M Meyer","year":"2013","unstructured":"Meyer, M.  et al. Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res. Ther. 15, R210 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201649_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/mmr.2013.1764","volume":"9","author":"KS Kim","year":"2014","unstructured":"Kim, K. S.  et al. Serum adipokine levels in rheumatoid arthritis patients and their contributions to the resistance to treatment. Mol. Med. Rep. 9, 255\u2013260 (2014).","journal-title":"Mol. Med. Rep."},{"key":"BFnrrheum201649_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cyto.2013.05.001","volume":"64","author":"L Andres Cerezo","year":"2013","unstructured":"Andres Cerezo, L.  et al. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Cytokine 64, 441\u2013447 (2013).","journal-title":"Cytokine"},{"key":"BFnrrheum201649_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10067-014-2704-1","volume":"34","author":"K Makrilakis","year":"2014","unstructured":"Makrilakis, K., Fragiadaki, K., Smith, J., Sfikakis, P. P. & Kitas, G. D. Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade. Clin. Rheumatol. 34, 419\u2013427 (2014).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum201649_CR47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1359\/jbmr.091106","volume":"25","author":"S Muruganandan","year":"2010","unstructured":"Muruganandan, S., Roman, A. A. & Sinal, C. J. Role of chemerin\/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J. Bone Miner. Res. 25, 222\u2013234 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum201649_CR48","doi-asserted-by":"publisher","first-page":"e109524","DOI":"10.1371\/journal.pone.0109524","volume":"9","author":"C Swales","year":"2014","unstructured":"Swales, C., Athanasou, N. A. & Knowles, H. J. Angiopoietin-like 4 is over-expressed in rheumatoid arthritis patients: association with pathological bone resorption. PLoS ONE 9, e109524 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201649_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2013.11.040","volume":"443","author":"MA Murayama","year":"2014","unstructured":"Murayama, M. A.  et al. CTRP3 plays an important role in the development of collagen-induced arthritis in mice. Biochem. Biophys. Res. Commun. 443, 42\u201348 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201649_CR50","doi-asserted-by":"publisher","unstructured":"Dikbas, O.  et al. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity. Int. J. Rheum. Dis. http:\/\/dx.doi.org\/10.1111\/1756-185X.12444 (2014).","DOI":"10.1111\/1756-185X.12444"},{"key":"BFnrrheum201649_CR51","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1136\/annrheumdis-2012-202325","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder, L.  et al. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann. Rheum. Dis. 72, 1956\u20131961 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR52","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.38968","volume":"67","author":"U Syrbe","year":"2015","unstructured":"Syrbe, U.  et al. Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. Arthritis Rheumatol. 67, 678\u2013685 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201649_CR53","first-page":"538","volume":"31","author":"JA Miranda-Filloy","year":"2013","unstructured":"Miranda-Filloy, J. A.  et al. Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-\u03b1 antagonist therapy. Clin. Exp. Rheumatol. 31, 538\u2013545 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201649_CR54","first-page":"913","volume":"31","author":"F Genre","year":"2013","unstructured":"Genre, F.  et al. Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-\u03b1 therapy. Clin. Exp. Rheumatol. 31, 913\u2013918 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201649_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.molmet.2015.01.002","volume":"4","author":"C Ma","year":"2015","unstructured":"Ma, C.  et al. Genetic determination of the cellular basis of the ghrelin-dependent bone remodeling. Mol. Metab. 4, 175\u2013185 (2015).","journal-title":"Mol. Metab."},{"key":"BFnrrheum201649_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/annrheumdis-2013-204189","volume":"73","author":"J Conde","year":"2014","unstructured":"Conde, J.  et al. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann. Rheum. Dis. 73, 631\u2013633 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR57","doi-asserted-by":"publisher","first-page":"e0123601","DOI":"10.1371\/journal.pone.0123601","volume":"10","author":"J Conde","year":"2015","unstructured":"Conde, J.  et al. Identification of novel adipokines in the joint. Differential expression in healthy and osteoarthritis tissues. PLoS ONE 10, e0123601 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201649_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jor.22585","volume":"32","author":"M Scotece","year":"2014","unstructured":"Scotece, M.  et al. NUCB2\/nesfatin-1: a new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study. J. Orthop. Res. 32, 653\u2013660 (2014).","journal-title":"J. Orthop. Res."},{"key":"BFnrrheum201649_CR59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/annrheumdis-2012-201693","volume":"72","author":"J Conde","year":"2013","unstructured":"Conde, J.  et al. Expression and modulation of adipolin\/C1qdc2: a novel adipokine in human and murine ATDC-5 chondrocyte cell line. Ann. Rheum. Dis. 72, 140\u2013142 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.drudis.2013.07.012","volume":"19","author":"M Scotece","year":"2013","unstructured":"Scotece, M.  et al. Adipokines as drug targets in joint and bone disease. Drug Discov. Today 19, 241\u2013258 (2013).","journal-title":"Drug Discov. Today"},{"key":"BFnrrheum201649_CR61","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara, A.  et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426\u2013430 (2005).","journal-title":"Science"},{"key":"BFnrrheum201649_CR62","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.4049\/jimmunol.176.7.4468","volume":"176","author":"A Ehling","year":"2006","unstructured":"Ehling, A.  et al. The potential of adiponectin in driving arthritis. J. Immunol. 176, 4468\u20134478 (2006).","journal-title":"J. Immunol."},{"key":"BFnrrheum201649_CR63","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1186\/ar2844","volume":"11","author":"HM Choi","year":"2009","unstructured":"Choi, H. M.  et al. Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. Arthritis Res. Ther. 11, R161 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201649_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbrc.2008.11.017","volume":"378","author":"K Kitahara","year":"2009","unstructured":"Kitahara, K., Kusunoki, N., Kakiuchi, T., Suguro, T. & Kawai, S. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 378, 218\u2013223 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201649_CR65","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.4049\/jimmunol.179.8.5483","volume":"179","author":"CH Tang","year":"2007","unstructured":"Tang, C. H., Chiu, Y. C., Tan, T. W., Yang, R. S. & Fu, W. M. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, 38, and NF-\u03baB pathway. J. Immunol. 179, 5483\u20135492 (2007).","journal-title":"J. Immunol."},{"key":"BFnrrheum201649_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbrc.2008.11.005","volume":"378","author":"K Ebina","year":"2009","unstructured":"Ebina, K.  et al. Adenovirus-mediated gene transfer of adiponectin reduces the severity of collagen-induced arthritis in mice. Biochem. Biophys. Res. Commun. 378, 186\u2013191 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201649_CR67","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/03009740801910346","volume":"37","author":"SW Lee","year":"2008","unstructured":"Lee, S. W., Kim, J. H., Park, M. C., Park, Y. B. & Lee, S. K. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand. J. Rheumatol. 37, 260\u2013268 (2008).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrrheum201649_CR68","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/art.22833","volume":"56","author":"F Brentano","year":"2007","unstructured":"Brentano, F.  et al. Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum. 56, 2829\u20132839 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201649_CR69","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","volume":"178","author":"AR Moschen","year":"2007","unstructured":"Moschen, A. R.  et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 178, 1748\u20131758 (2007).","journal-title":"J. Immunol."},{"key":"BFnrrheum201649_CR70","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/art.21942","volume":"54","author":"MA Nowell","year":"2006","unstructured":"Nowell, M. A.  et al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 54, 2084\u20132095 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201649_CR71","doi-asserted-by":"publisher","first-page":"e2267","DOI":"10.1371\/journal.pone.0002267","volume":"3","author":"N Busso","year":"2008","unstructured":"Busso, N.  et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase\/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS ONE 3, e2267 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201649_CR72","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.290.13.1709-c","volume":"290","author":"A Schaffler","year":"2003","unstructured":"Schaffler, A.  et al. Adipocytokines in synovial fluid. JAMA 290, 1709\u20131710 (2003).","journal-title":"JAMA"},{"key":"BFnrrheum201649_CR73","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/rheumatology\/ken187","volume":"47","author":"H Forsblad d'Elia","year":"2008","unstructured":"Forsblad d'Elia, H., Pullerits, R., Carlsten, H. & Bokarewa, M. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 47, 1082\u20131087 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201649_CR74","first-page":"698","volume":"24","author":"K Migita","year":"2006","unstructured":"Migita, K.  et al. The serum levels of resistin in rheumatoid arthritis patients. Clin. Exp. Rheumatol. 24, 698\u2013701 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201649_CR75","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U. & Tarkowski, A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174, 5789\u20135795 (2005).","journal-title":"J. Immunol."},{"key":"BFnrrheum201649_CR76","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","volume":"334","author":"N Silswal","year":"2005","unstructured":"Silswal, N.  et al. Human resistin stimulates the pro-inflammatory cytokines TNF-\u03b1 and IL-12 in macrophages by NF-\u03baB-dependent pathway. Biochem. Biophys. Res. Commun. 334, 1092\u20131101 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum201649_CR77","first-page":"311","volume":"26","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay, M. A.  et al. Anti-TNF-\u03b1 therapy modulates resistin in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 26, 311\u2013316 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201649_CR78","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0026-0495(99)90174-9","volume":"48","author":"HJ Anders","year":"1999","unstructured":"Anders, H. J., Rihl, M., Heufelder, A., Loch, O. & Schattenkirchner, M. Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48, 745\u2013748 (1999).","journal-title":"Metabolism"},{"key":"BFnrrheum201649_CR79","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/01.smj.0000240625.27772.79","volume":"99","author":"R Gunaydin","year":"2006","unstructured":"Gunaydin, R.  et al. Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South. Med. J. 99, 1078\u20131083 (2006).","journal-title":"South. Med. J."},{"key":"BFnrrheum201649_CR80","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/rheumatology\/keh421","volume":"44","author":"E Toussirot","year":"2005","unstructured":"Toussirot, E.  et al. Relationship between growth hormone\u2013IGF-I\u2013IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) 44, 120\u2013125 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201649_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00296-006-0264-7","volume":"27","author":"S Hizmetli","year":"2007","unstructured":"Hizmetli, S., Kisa, M., Gokalp, N. & Bakici, M. Z. Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol. Int. 27, 335\u2013338 (2007).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum201649_CR82","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00296-006-0253-x","volume":"27","author":"SW Lee","year":"2007","unstructured":"Lee, S. W., Park, M. C., Park, Y. B. & Lee, S. K. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol. Int. 27, 537\u2013540 (2007).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum201649_CR83","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/ard.62.10.913","volume":"62","author":"G Palmer","year":"2003","unstructured":"Palmer, G. & Gabay, C. A role for leptin in rheumatic diseases? Ann. Rheum. Dis. 62, 913\u2013915 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR84","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/ard.2004.032243","volume":"64","author":"C Popa","year":"2005","unstructured":"Popa, C.  et al. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann. Rheum. Dis. 64, 1195\u20131198 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR85","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3899\/jrheum.080626","volume":"36","author":"C Popa","year":"2009","unstructured":"Popa, C.  et al. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. J. Rheumatol. 36, 724\u2013730 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201649_CR86","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/ard.2005.040857","volume":"65","author":"P Harle","year":"2006","unstructured":"Harle, P., Sarzi-Puttini, P., Cutolo, M. & Straub, R. H. No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann. Rheum. Dis. 65, 970\u2013971 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201649_CR87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1358\/dnp.2006.19.1.966243","volume":"19","author":"M Otero","year":"2006","unstructured":"Otero, M.  et al. Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Drug News Perspect. 19, 21\u201326 (2006).","journal-title":"Drug News Perspect."},{"key":"BFnrrheum201649_CR88","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/rheumatology\/kel157","volume":"45","author":"M Otero","year":"2006","unstructured":"Otero, M.  et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45, 944\u2013950 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201649_CR89","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.febslet.2004.11.024","volume":"579","author":"M Otero","year":"2005","unstructured":"Otero, M.  et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 579, 295\u2013301 (2005).","journal-title":"FEBS Lett."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.49","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:08:15Z","timestamp":1650388095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFnrrheum201649"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2016.49","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]},"assertion":[{"value":"15 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}